順絡電子(002138.SZ):擬向交通銀行深圳分行申請授信額度不超14億元
格隆匯 10 月 20日丨順絡電子(002138.SZ)公佈,公司第五屆董事會第三十五次會議決議,審議通過了《關於向交通銀行股份有限公司深圳分行申請授信額度不超過人民幣壹拾肆億元(含等值外幣)的議案》;
公司擬向交通銀行股份有限公司深圳分行申請授信額度不超過人民幣14億元(含等值外幣),其中綜合授信額度不超過人民幣3億元,銀團貸款項下綜合授信額度不超過人民幣11億元,由交通銀行股份有限公司深圳分行作為銀團貸款牽頭行,參加行為中國農業銀行股份有限公司深圳中心區支行,董事會授權公司總裁在不超過以上貸款金額的範圍內具體辦理相關貸款事宜,本授權有效期至下次董事會決議修訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.